Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Anesthetics with NGX-4010 for Neuropathic Pain
NCT00082316Phase 2Completed
- Sponsor
- NeurogesX
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of capsaicin 8% patch in neuropathic pain (3 arms), sponsored by NeurogesX. Primary endpoint: Percentage Change in Numeric Pain Rating Scale (NPRS) Scores at 12 weeks. Status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00082316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082316.